WEDNESDAY, Jan. 29, 2025 (HealthDay News) -- Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence review suggests.

WEDNESDAY, Jan. 29, 2025 (HealthDay News) -- Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence review suggests. These patients might ...

Nearly 41% of patients treated with platinum-based chemo developed nerve pain, as well as just over 38% of those treated with taxanes, results show. Nerve pain was most common in lung cancer ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

Discover new treatments like ART-123 advancing toward approval to prevent long-term nerve damage caused by ...

Patients might experience weakness, loss of balance and coordination, numbness or tingling WEDNESDAY, Jan. 29, 2025 (HealthDay News) -- Four in every 10 cancer patients treated with chemotherapy ...

Halneuron, a NaV 1.7 sodium channel inhibitor, is being tested for chemotherapy-induced neuropathic pain, offering a potential opioid alternative. Previous trials showed Halneuron significantly ...

Stabbing, burning or tingling pain can be chronic in cancer patients who undergo chemotherapy. A new study found that 4 in 10 patients get persistent and severe nerve pain from the cancer treatment.

“Chemo belly” is a grouping of several side effects of chemotherapy drugs on the gastrointestinal (GI) ... In addition to bloating, gas, discomfort, and abdominal pain, ...

How Does Chemotherapy Treat Inflammatory and Autoimmune Diseases? In many rheumatic diseases, inflammation causes damage to parts of the body; for example - causing painful joints as in rheumatoid ...